Results 281 to 290 of about 13,250,277 (360)

Apolipoprotein B Subspecies of VLDL in Primary Hyperlipoproteinemia and Diabetes Mellitus

open access: bronze, 1986
Hirotada Takai   +6 more
openalex   +2 more sources

Lipids, apolipoproteins, carbohydrates, and risk of hematological malignancies. [PDF]

open access: yesEur J Epidemiol
Liu Q   +8 more
europepmc   +1 more source

Proteome of Renal Tubuli and Serum Differentiate Pre‐Existing Type 2 Diabetes and Post‐Transplant Diabetes in Kidney Transplant Recipients

open access: yesPROTEOMICS – Clinical Applications, EarlyView.
ABSTRACT Purpose Diabetes mellitus (DM) is a major cause of end‐stage kidney disease (ESKD), with kidney transplantation being the preferred treatment. However, post‐transplant diabetes mellitus (PTDM) increases mortality and graft loss. While PTDM and Type 2 diabetes mellitus (T2DM) share risk factors, their mechanisms differ, particularly in diabetic
Eleni Skandalou   +7 more
wiley   +1 more source

Relationship between Apolipoprotein B-48 Retention and Apolipoprotein Composition of Very Low Density Lipoproteins in Hemodialysis Patients

open access: bronze, 1987
Toshihiko MIYAI   +6 more
openalex   +2 more sources

Per- and polyfluoroalkyl substances, apolipoproteins and the risk of coronary heart disease in US men and women. [PDF]

open access: yesEnviron Health
Zhu L   +7 more
europepmc   +1 more source

Human monocyte colony-stimulating factor enhances the clearance of lipoproteins containing apolipoprotein B-100 via both low density lipoprotein receptor-dependent and -independent pathways in rabbits.

open access: hybrid, 1990
Hitoshi Shimano   +9 more
openalex   +1 more source

Population Pharmacokinetics and Exposure‐Response Modeling for Evinacumab in Children, Adolescents, and Adults With Homozygous Familial Hypercholesterolemia

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Evinacumab, an angiopoietin‐like 3 (ANGPTL3) inhibitor, significantly reduces low‐density lipoprotein cholesterol (LDL‐C), independent of low‐density lipoprotein receptor, in patients with homozygous familial hypercholesterolemia (HoFH). A population pharmacokinetic (PK)/pharmacodynamic (PD) model was previously developed to characterize ...
Sébastien Bihorel   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy